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Background: Recent evolution of minimally invasive technology has expanded the
application of the right thoracotomy approach for mitral valve surgery. These same
technological advances have also made the left posterior minithoracotomy approach
attractive in complex mitral procedures.
Methods: From 1996 to 2003, 921 isolated mitral valve procedures were performed
without sternotomy; 40 (4.3%) of these were performed via left posterior minitho-
racotomy. In the left posterior minithoracotomy group, ages ranged from 18 to 84
years; 36 patients had had previous cardiac surgery (9 on 2 occasions). Other
factors precluding right thoracotomy included mastectomy/radiation and pectus
excavatum.
Results: Arterial perfusion was via femoral artery (n  26) or descending aorta (n
 14); long femoral venous cannulas with vacuum-assisted drainage were used in
39 procedures. Two patients had direct aortic crossclamping, 18 had hypothermic
fibrillation, and 20 had balloon endoaortic occlusion. The mean crossclamp and
bypass times were 81.9 and 117.2 minutes, respectively. Hospital mortality was
5.0% (2/40); both deaths occurred in octogenarians. There were no injuries to
bypass grafts or conversions to sternotomy. Complications included perioperative
stroke (2/40; 5.0%), bleeding (2/40; 5.0%), and respiratory failure (1/40; 2.5%); 28
patients (70%) had no postoperative complications. There was no incidence of
perioperative myocardial infarction, renal failure, sepsis, or wound infection. The
median length of stay was 7 days.
Conclusions: Advances in minimally invasive cardiac surgery technology are
readily adaptable to a left-sided minithoracotomy approach to the mitral valve. The
left posterior minithoracotomy approach is a valuable option in complicated reop-
erative mitral procedures with acceptable perioperative morbidity and mortality.
Since the advent of minimally invasive cardiac surgery, the rightthoracotomy approach has become widely accepted for mitral valveprocedures.1-4 The combination of safe cannulation techniques andthe excellent exposure attainable from the right chest has mademinimally invasive mitral valve surgery an increasingly attractiveoption. Minimally invasive mitral surgery has been associated with
mortality rates of 1.2% to 5.8%, along with less morbidity and a shorter length of
stay compared with the conventional sternotomy approach.1,2 Additionally, avoid-
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ing traditional sternotomy is often associated with enhanced
recovery5,6 and better patient satisfaction.7
For some patients, however, a right thoracotomy ap-
proach is relatively contraindicated. Most often this is be-
cause of a previous cardiac or thoracic operation, but prior
right-sided mastectomy with chest wall radiation may also
preclude a right-sided approach. In such cases, minimally
invasive nonsternotomy mitral valve procedures are still
possible by using a left posterior minithoracotomy (LPMT).
The left-sided approach also offers some unique advan-
tages, including a wider angle of vision and a shorter
distance for the surgeon to the mitral valve.8
Recent reports have shown the left thoracotomy ap-
proach for mitral valve surgery to be safe, although the
numbers of patients in these studies have been small.8-11 We
examined our recent institutional experience with LPMT
mitral surgery and its evolution with minimally invasive
technology.
Methods
Patient Clinical Characteristics
From 1996 to 2003, 921 mitral valve procedures were performed
without sternotomy; 40 (4.3%) of these were performed via
LPMT. Patient clinical characteristics are summarized in Table 1.
The mean age within the LPMT group was 56.5 years (range,
18-84 years). Thirty-six patients had undergone previous cardiac
operations, 7 had undergone 2 prior operations, and 2 patients had
undergone 3 or more prior operations; the mean time from the last
operation was 44.2 months. Data on prior cardiac operations are
included in Table 2. Twenty-one patients had undergone a previ-
ous right thoracotomy. Other factors that precluded right thoracot-
omy included mastectomy/radiation (n 3) and pectus excavatum
(n  1). Mitral valve pathology in this group included mitral
insufficiency in 25 patients (62.5%), mitral stenosis in 2 patients
(5%), and prosthetic valve dysfunction in 5 patients (12.5%).
Endocarditis was present in 7 patients (17.5%).
Surgical Approach
Mitral valve procedures were performed with the patient in right
lateral decubitus position and with single-lung ventilation tech-
niques. Transesophageal echocardiography (TEE) was performed
routinely in all cases. A left posterolateral minithoracotomy inci-
sion (approximately 6-8 cm) was made in the fourth, fifth, or sixth
intercostal space, and the lung was retracted inferiorly to expose
the heart. Figure 1 shows the incision and typical exposure of the
descending aorta for direct cannulation. The pericardium was
opened posterior to the phrenic nerve and retracted with retention
sutures, and the left atrium was opened along the base of the left
atrial appendage. Intra-atrial retractors were positioned by using a
self-retaining retractor, providing exposure of the mitral valve
(Figure 2). Standard mitral repair and replacement techniques were
used, and the operative field was flooded with CO2. After the
mitral procedure, the left atrium was closed in 2 layers with 3-0
Prolene sutures (Ethicon, Inc, Somerville, NJ). Deairing was
achieved through a transvalvular vent placed through the atriotomy
and optionally via a needle placed in the left ventricular apex.
Valvular function, myocardial performance, and intracardiac
deairing were monitored with TEE.
Perfusion Technique
Either femoral or direct descending aortic arterial cannulation was
used; vacuum-assisted venous drainage was used routinely. When
both femoral arterial and venous cannulation were used, a short
(approximately 3 cm) transverse left groin incision allowed expo-
sure of the left femoral artery and vein. In these patients, a
Heartport arterial cannula (CardioVations; Ethicon) was used, and
a 22F long venous cannula (CardioVations) was placed through an
anterior pursestring in the femoral vein by using the Seldinger
TABLE 1. Patient clinical characteristics (n  40)
Characteristic Data
Age, (y) (mean  SD) 56.5 17
Age 80 y 3 (7.5%)
Valve pathology
Mitral regurgitation 25 (62.5%)
Mitral stenosis 2 (5%)
Mitral stenosis and mitral regurgitation 6 (15%)
Prosthetic valve dysfunction 5 (12.5%)
Endocarditis 7 (17.5%)
Previous right MRM/RT 3 (7.5%)
Pectus excavatum 1 (2.5%)
Urgent or emergency operation 20 (50%)
Comorbidities
CHF 12 (30%)
COPD 3 (7.5%)
Peripheral vascular disease 3 (7.5%)
Previous MI 14 (35%)
Diabetes 1 (2.5%)
Preoperative stroke or TIA 1 (2.5%)
Renal disease 0
MRM/RT, Modified radical mastectomy/radiation therapy; CHF, congestive
heart failure; COPD, chronic obstructive pulmonary disease; MI, myocar-
dial infarction; TIA, transient ischemic attack.
TABLE 2. Previous cardiac procedures
Variable Data
Patients with a prior cardiac procedure 36
Patients with 1 prior cardiac procedure 9
Mean length to reoperation, mo (mean  SEM) 44.2 9
Prior procedures performed (n  51)
Mitral valve replacement 12
Mitral valve repair 20
Mitral valve commisurotomy 7
Aortic valve replacement 8
CABG 4
Prior approaches used (n  36)
Right thoracotomy 17
Median sternotomy 15
Right thoracotomy and median sternotomy 4
CABG, Coronary artery bypass grafting.
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technique. TEE guidance was used to verify arterial and venous
guidewires and position the endoclamp and distal tip of the venous
cannula.12 In those patients in whom central aortic cannulation was
used, the descending aorta was cannulated directly, and a long
venous cannula was percutaneously placed through the left femo-
ral vein.
Myocardial Protection
Myocardial protection strategies included either aortic occlusion
with retrograde cardioplegia or perfused cold fibrillation (22°C-
25°C). When endoaortic balloon clamp technology was used,
cardioplegia was delivered either retrograde via a transjugular
coronary sinus catheter or antegrade via the endoclamp catheter.
Figure 1. Left posterior minithoracotomy with direct descending aortic cannulation.
Figure 2. Surgeon’s view of the left atrial exposure. Note that the mitral valve orientation is upside down, with the
posterior annulus anterior, as compared with the orientation seen with the sternotomy and right thoracotomy
approaches.
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Data Collection
All data were prospectively collected by trained nurse clinicians
and entered into an institutional database. The database conforms
to the definitions used by the New York State Cardiac Surgery
Reporting System, an audited data-collection instrument used to
record and analyze all cardiac operations performed in New York.
Follow-up survival was ascertained from the Social Security Death
Index.
Data were retrospectively analyzed with SPSS statistical soft-
ware (version 11; SPSS, Inc, Chicago, Ill). Results are expressed
as the mean  SD unless otherwise indicated.
Results
A summary of operative techniques is found in Table 3.
Half of the operations (20/40) were performed through the
sixth intercostal space; there were no conversions to ster-
notomy. Femoral arterial cannulation was used in 65%
(26/40) of patients, and descending aortic cannulation was
used in the remainder. Femoral venous cannulation was
used in all 40 patients. In the first operation performed
(without vacuum assistance), femoral venous drainage was
augmented with an additional pulmonary artery cannula.
Endoaortic balloon occlusion was used in 50% (20/40), and
retrograde cardioplegia was given via transjugular coronary
sinus catheter in 9 of these (45%). Two early patients had
direct aortic clamping. Cold perfusion and fibrillation were
used in 18 patients. The mean bypass time was 117.2  35
minutes, and the mean crossclamp time (when used; n 22)
was 81.9  22 minutes.
In the 15 operations performed since 2001, descending
aortic cannulation was used in 87% (13/15), and similarly
87% (13/15) were performed with hypothermic fibrillation.
All 15 of these operations used CO2 in the operative field,
and the mean bypass time among this group was 27 minutes
shorter than before 2001 (102.1  27.5 minutes vs 129.8 
35.6 minutes; P  .006).
Hospital mortality occurred in 2 patients (5%), both
octogenarians. One death occurred after an intraoperative
posterior ventricular wall rupture in a patient who had
undergone previous aortic valve replacement and coronary
artery bypass grafting; the other death was associated with
a perioperative stroke. Among the 36 patients undergoing
reoperative operations, the mortality was 2.8% (1/36). With
95% follow-up, there has been 1 additional postoperative
death, which took place 1 year after surgery. Postoperative
morbidity is listed in Table 4. Postoperative stroke occurred
in 7.5% (3/40); 2 strokes occurred perioperatively, and 1
occurred 1 week after surgery. Two patients underwent
reoperation for bleeding. There were no reported instances
of exposure injuries to cardiac structures or previous bypass
grafts, aortic dissections, or deep chest wound infections. In
28 (70%) of 40 patients, there were no major complications.
The median hospital length of stay was 7.0 days.
Discussion
This experience represents a large contemporary series of
mitral valve operations with a left thoracotomy approach.
The left-sided approach has existed for cardiac procedures
since 1910, when Alexis Carrel13 proposed it for a coronary
artery bypass from the thoracic aorta. Some of the earliest
mitral valve interventions were also performed with this
approach; in the 1960s, mitral valvuloplasties were com-
monly approached from the left side.14,15 However, as me-
dian sternotomy became the standard approach for cardiac
operations, the left thoracotomy fell out of favor.16
TABLE 3. Operative techniques (n  40)
Variable Data
Procedures performed
Mitral replacement 30 (75%)
Mitral repair 5 (12.5%)
Repair of paravalvular leak 5 (12.5%)
Surgical approach
Left posterior minithoracotomy 40/40
Converted to median sternotomy 0
CO2 used 23 (57.5%)
Interspace used
Fourth 9 (22.5%)
Fifth 11 (27.5%)
Sixth 20 (50%)
Perfusion
Descending aortic cannulation 14 (35%)
Femoral arterial cannulation 26 (65%)
Femoral venous cannulation 40 (100%)
Myocardial protection
Hypothermic fibrillation 18 (45%)
Direct ascending aortic crossclamp 2 (5%)
Endoaortic balloon clamp 20 (50%)
Antegrade cardioplegia 13/22 (59%)
Retrograde cardioplegia via
percutaneous transjugular
coronary sinus catheter
9/22 (41%)
TABLE 4. Postoperative morbidity and mortality (n  40)
Variable Data
Hospital death 2 (5%)
Median ventilation time (h) 10.5
Median total hospital stay (d) 7
Complication free 28 (70%)
Complications
CVA 3 (7.5%)
GI complication 1 (2.5%)
Respiratory failure 1 (2.5%)
Reoperation for bleeding 2 (5%)
Aortic dissection 0
Transmural MI 0
Deep chest wound infection 0
New renal failure 0
Sepsis 0
CVA, Cerebrovascular accident; GI, gastrointestinal; MI, myocardial infarc-
tion.
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The 1990s saw an explosion of minimally invasive tech-
niques in cardiac operations, fueled by new technology and
driven by the desire for shorter hospital stays and improved
patient satisfaction. Minimally invasive approaches for both
coronary artery bypass and valve surgery became widely
performed at many centers around the world,7,17,18 and, by
using port access technology, mitral valve surgery via right
thoracotomy has gained popularity.4,19,20 At our institution
and others, the approach of choice to the mitral valve is the
right anterior minithoracotomy approach.21
The potential of minimally invasive approaches for reop-
erative mitral valve surgery has been explored as well.22,23
Avoidance of reoperative sternotomy has allowed for shorter
hospital stays, earlier return to work, and fewer transfusions,
with morbidity and mortality similar to those of sternotomy.24
The left thoracotomy approach has been advocated for reop-
erative coronary artery bypass graft by a number of cen-
ters.25-27 Grosner and colleagues28 and Lajos and associates29
have reported a large series of 90 left thoracotomy coronary
artery bypass graft patients followed up over 10 years; they cite
the advantages of safer exposure in the setting of patent bypass
grafts with similar morbidity and mortality.
Using left thoracotomy approaches, Hughes and col-
leagues11 reported a case of combined transmyocardial re-
vascularization and mitral valve replacement, and Pratt and
colleagues9 described a mitral replacement in a patient who
had previously undergone esophagogastrectomy with a sub-
sternal gastric conduit. Combined coronary artery bypass
graft and mitral procedures using a left-sided approach have
been reported.30 Van Nooten and colleagues10 reported 10
cases of reoperative mitral valve procedures that used a left
thoracotomy, peripheral cannulation, and an endoclamp.
Repossini and colleagues8 reported on 11 patients who
underwent mitral valve operations with left thoracotomy, all
via femoral cannulation with direct aortic crossclamping.
However, this series contained only 1 patient undergoing
reoperation, which, in our experience, makes anatomic dis-
section of the aorta for direct clamping more adventurous.
In our series of 40 patients, the minimally invasive
technique has evolved since its initial use in 1996. In the
early experience, all cannulation was performed via the
femoral vessels, most cases were performed with endoaortic
balloon clamps, and transjugular coronary sinus catheters
were frequently used for the administration of retrograde
cardioplegia. In our more recent experience, most cases
have been performed more simply by using hypothermic
fibrillation and direct aortic cannulation. With central aortic
cannulation, the issues of obstructive peripheral vascular
disease, small femoral arterial size (particularly in women),
and possible groin complications have been avoided.31 With
the routine use of vacuum-assisted drainage, long venous
cannulation achieves excellent drainage while minimizing
the risk of gaseous microemboli.32 Performing operations
under hypothermic fibrillation avoids the use of the balloon
endoclamp,33 which can be more difficult to correct in the
right lateral decubitus position without direct access to the
ascending aorta. However, the presence of moderate aortic
insufficiency remains an indication for the endoclamp tech-
nique. Self-retaining intra-atrial retractors, which are rou-
tinely used for all minimally invasive mitral procedures,
allow for optimal exposure through a small incision.
The evolution of this technique has been driven by
increased experience with less-invasive strategies and
greater comfort with the technology used. In its current
form, the left thoracotomy approach is simpler and more
adaptable to each individual patient than in its early phases.
As a result, the mean cardiopulmonary bypass time has
decreased by approximately 30 minutes since 2001.
This series of patients included 36 patients undergoing
reoperative mitral valve operations, 9 of whom had undergone
multiple previous procedures. Our experience has shown this
approach to be safe and reproducible, with acceptable morbid-
ity and mortality in this high-risk subset of patients, and,
significantly, there were no exposure injuries to cardiac struc-
tures or bypass grafts. Because the number of reoperative valve
procedures continues to increase, safe approaches for reopera-
tive valve operations are increasingly important.
As minimally invasive cardiac surgery begins to involve
more endoscopic and robotic technology, the left thoracot-
omy approach may also have specific advantages of its own.
By allowing access to the descending aorta for placement of
proximal anastomoses, a left-sided approach may facilitate
combined mitral and coronary procedures by using endo-
scopic or robotic techniques.34
There are some disadvantages inherent in a left thoracot-
omy, however, most notably the poor access to the ascend-
ing aorta for direct crossclamping, especially in the reop-
erative setting. Also, the orientation of the mitral valve from
this exposure is such that it is inverted compared with that
achieved from the right side.
Conclusion
Advances in minimally invasive cardiac surgery technology
are readily adaptable to a left-sided minithoracotomy ap-
proach to the mitral valve. LPMT is a valuable option in
complicated reoperative mitral valve procedures, with ac-
ceptable perioperative morbidity and mortality.
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Discussion
Dr James Fann (Stanford, Calif). Dr Saunders, New York
University has been one of the leaders in minimally invasive
cardiac surgery and has indeed advanced our knowledge of mitral
valve surgery by employing innovative techniques. I want to
congratulate you and your colleagues on the presentation and the
use of limited left thoracotomy approach for again bringing to our
attention the use of this unique approach.
Given the fact that only 4.3% of the nonsternotomy cases are
performed in this fashion, one can consider this as probably a
distant second when it comes to a nonsternotomy approach to the
mitral valve. My questions mainly deal with the technical aspects
of this procedure. The mitral valve is rotated from the conventional
right-sided approach, as you mentioned, and I wonder if this angle
of approach is more difficult: that is, is there any trick when it
comes to exposing the mitral valve from the left side?
Dr Saunders. Thank you very much for your comments. You
are correct; this is definitely a distant second to the right anterior
thoracotomy approach, but it has a very specific indication. While
it is not our approach of choice, it is a valuable option in certain
difficult patient situations.
While we find the exposure to be very good, the valve is
obviously upside down as compared to the right-sided approach.
With respect to exposure, we find that silk retraction sutures and
self-retaining retractors are all that we need to obtain good visu-
alization.
Dr Fann. In 50% of the cases the sixth intercostal space was
used, and in 25% of the cases either the fourth or fifth intercostal
space was used as the approach. Is there a good way of determin-
ing which intercostal space is the best approach for a left thora-
cotomy?
Dr Saunders. There are no specific maneuvers we use to
determine the intercostal space to use; mostly this depends on
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individual surgeon preference and the patient’s particular body
habitus.
Dr Fann. Two patients had direct aortic crossclamping. Why
was this technique limited to 2 patients, as opposed to being
utilized in more of the patients in this particular group?
Dr Saunders. Those 2 were actually 2 of the first 3 that
underwent this procedure. Exposure of the aorta is very difficult
from this approach, especially in reoperative cases. Although some
authors that have written about this approach routinely use direct
aortic crossclamping, we feel that this is difficult as a standard
technique.
Dr Fann. There were no femoral arterial complications re-
ported in this series, and this complication has been infrequent in
previous series from New York University. Why has the prefer-
ence been to use the descending aorta for cannulation?
Dr Saunders. As our experience with right thoracotomy mitral
valve surgery has evolved, we have moved away from routine use
of endoballoon catheters toward direct ascending aortic cannula-
tion and crossclamping. This serves to make the case simpler and
more efficient and may decrease the bypass time and total case
time. It also limits the number of complications associated with
endoballoons, in terms of aortic dissection or balloon migration.
Dr Fann. In this patient population, the frequency of athero-
sclerosis is typically not very high, but given your institutional
experience with evaluating the ascending aorta prior to cannula-
tion, do you examine the descending thoracic aorta with TEE for
any intraluminal disease prior to cannulation?
Dr Saunders. We do, using a combination of TEE prior to
aortic cannulation and direct palpation of the aorta by the operating
surgeon.
Dr Fann. And in the fibrillatory arrest subset, do you think that
the deairing is a problem, or is a transvalvular vent and flooding
the field with CO2 adequate?
Dr Saunders. We find the deairing we can achieve from this
approach to be adequate, but in addition to the transvalvular vent,
we occasionally access the left ventricle directly, using a needle,
for additional deairing. We also use the combination of typical
maneuvers in changing the position of the table to augment deair-
ing. Again, at the conclusion of the case, TEE is used to assess
intracardiac air.
Dr Fann. And finally, in the 2 patients with the perioperative
strokes, were those cases performed with descending aortic can-
nulation and fibrillatory arrest, and what was the method of deair-
ing in those 2 patients?
Dr Saunders. Those 2 patients were actually early in our
experience, and both had femoral arterial cannulation and endoaor-
tic balloon clamping. There were no strokes in the later group,
although we have to say that in our larger overall series of
minimally invasive cases, we have never found a correlation
between use of the endoballoon catheter and strokes.
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